Show simple item record

Authordc.contributor.authorOkada, Takuya
Authordc.contributor.authorTanaka, Koji
Authordc.contributor.authorKawachi, Hiroshi
Authordc.contributor.authorIto, Takashi
Authordc.contributor.authorNishikage, Tetsuro
Authordc.contributor.authorOdagaki, Tomoyuki
Authordc.contributor.authorZárate, Alejandro J.
Authordc.contributor.authorKronberg, Udo
Authordc.contributor.authorLópez Kostner, Francisco
Authordc.contributor.authorKarelovic, Stanko
Authordc.contributor.authorFlores, Sergio
Authordc.contributor.authorEstela Petit, Ricardo
Authordc.contributor.authorTsubaki, Masahiro
Authordc.contributor.authorUetake, Hiroyuki
Authordc.contributor.authorEishi, Yoshinobu
Authordc.contributor.authorKawano, Tatsuyuki
Admission datedc.date.accessioned2016-05-12T16:00:46Z
Available datedc.date.available2016-05-12T16:00:46Z
Publication datedc.date.issued2016
Cita de ítemdc.identifier.citationCancer 2016 ; 122:71-7en_US
Identifierdc.identifier.other10.1002/cncr.29715
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/138267
Abstractdc.description.abstractBACKGROUND: In Chile, mortality from colorectal cancer (CRC) has increased rapidly. To help address this issue, the Prevention Project for Neoplasia of the Colon and Rectum (PRENEC) program was initiated in 2012 with intensive support from Tokyo Medical and Dental University (TMDU) in Tokyo, Japan, as part of an international collaboration. METHODS: From June 2012 to July 2014, a total of 10,575 asymptomatic participants were enrolled in PRENEC. Participants with positive immunochemical fecal occult blood test (iFOBT) results or a family history of CRC underwent colonoscopy. The colonoscopy results from a similar, previous project in Chile (PREVICOLON) were compared with those from PRENEC. Furthermore, the initial colonoscopies of 1562 participants in PRENEC were analyzed according to whether the colonoscopists were from TMDU or Chile. RESULTS: The complete colonoscopy, adenoma detection, and cancer detection rates were 88.0%, 26.7%, and 1.1%, respectively, in PREVICOLON, while the corresponding values were 94.4%, 41.8%, and 6.0%, respectively, in PRENEC. In PRENEC, 107 cases of CRC were detected, amounting for 1.0% of all participants. Considering initial colonoscopies in PRENEC, the complete colonoscopy, adenoma detection, and cancer detection rates were 97.4%, 45.3%, and 9.3%, respectively, for physicians at TMDU and 93.3%, 41.5%, and 5.1%, respectively for Chilean physicians. The detection rates of intramucosal cancer were 7.3% and 3.7%, respectively, for TMDU and Chilean physicians. CONCLUSIONS: Quality indicators of colonoscopy substantially improved from PREVICOLON to PRENEC. The assessments made by Chilean physicians alone were improved in PRENEC, but remained better in the TMDU group. Moreover, physicians from TMDU detected more CRCs than Chilean physicians, especially at earlier stages.en_US
Lenguagedc.language.isoenen_US
Publisherdc.publisherAmerican Cancer Societyen_US
Type of licensedc.rightsAtribución-NoComercial-SinDerivadas 3.0 Chile*
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/*
Sourcedc.sourceCancer
Keywordsdc.subjectAdenoma detection rateen_US
Keywordsdc.subjectColorectal canceren_US
Keywordsdc.subjectColonoscopyen_US
Keywordsdc.subjectDiagnostic techniques and proceduresen_US
Keywordsdc.subjectInternational cooperationen_US
Keywordsdc.subjectScreeningen_US
Keywordsdc.subjectTraining programsen_US
Títulodc.titleInternational Collaboration Between Japan and Chile to Improve Detection Rates in Colorectal Cancer Screeningen_US
Document typedc.typeArtículo de revista
dcterms.accessRightsdcterms.accessRightsAcceso a solo metadatos


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Atribución-NoComercial-SinDerivadas 3.0 Chile
Except where otherwise noted, this item's license is described as Atribución-NoComercial-SinDerivadas 3.0 Chile